Home / Health / Alzheimer's Drug Repairs Brain DNA, Boosts Nerve Growth
Alzheimer's Drug Repairs Brain DNA, Boosts Nerve Growth
13 Jul
Summary
- Drug KCL-286 stimulates nerve growth by activating a specific protein.
- It repairs double-strand DNA breaks in neurons, common in Alzheimer's.
- Drug KCL-286 also calms brain inflammation by reducing microglia activity.
Scientists have identified a promising new drug, KCL-286, which targets DNA damage and inflammation early in Alzheimer's disease progression. This drug, already through Phase 1 safety trials, stimulates nerve growth by activating a specific protein within the retinoic acid pathway.
KCL-286 is designed to repair double-strand DNA breaks in neurons, a problem that occurs at higher rates in individuals with Alzheimer's. By boosting DNA repair factors like BRCA1, it actively addresses cellular damage. The drug also shows potential in reducing neuroinflammation.
Research indicates KCL-286 calms the brain's immune cells, microglia, and positively affects astrocytes. This dual action of repairing DNA and reducing inflammation positions KCL-286 as a potential disease-modifying therapy, rather than just a treatment for symptoms. Its development timeline could be significantly shortened due to prior safety testing.
